Men from the placebo group whose PSA had never exceeded 4.0 ng/ml, who had never previously undergone a prostate biopsy or transurethral prostate resection, and who had consistently normal results ...
New Prostate Biopsy Technique Lowers Infection Risk Sep ... Immunotherapy Shows Promise for Men With Specific Types of Prostate Cancer Sep. 16, 2024 — New research has shown that immunotherapy ...
New Prostate Biopsy Technique Lowers Infection Risk Sep ... immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their ...
Prostate cancer is the most common cancer in men, with an estimated one in eight Canadian men expected to be diagnosed in their lifetimes. Experts say improved screening tools can help more accurately ...
The 13,153 men with a PSA level of 3 ng/mL or higher underwent prostate MRI and were randomly assigned to MRI-targeted or systematic biopsy (with subsequent targeted biopsy if MRI was positive).
“We often hear prostate cancer described as a ‘good ... “without reducing the likelihood of them surviving their cancer.” Men had their biopsy sample taken when diagnosed, put on ...